Clinical-stage biopharmaceutical company developing small-molecule therapeutics targeting innate immune pathways for immunology, inflammation, and neurology.
Get notified the moment Ventus Therapeutics files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.